01
The benchmark could recognize the hospital
The common pooled protocol holds out subjects but leaves every dataset represented in both train and test folds. Because acquisition hardware, montage, filtering, and cohort composition differ by dataset, the model can learn where a recording came from—and site is correlated with the label.
A diagnostic null makes the confound visible: predict each dataset’s majority class without looking at EEG. On the reconstructed pooled protocol, that no-EEG baseline reaches 0.901 segment-level and 0.700 subject-level balanced accuracy, comparable to the trained headline results.
02
Hold out the site, not only the subject
Leave-one-dataset-out evaluation trains on several sites and tests on a site the model has never seen. That changes the scientific object from interpolation within a mixed benchmark to transfer across acquisition and population shift.
Under this protocol, the supervised model retains subject-level ROC-AUC of 0.763 ± 0.034 across three seeded runs. The signal is above chance, but far less deployment-ready than the pooled score implies.
03
Ranking survived better than the threshold
At a fixed 0.5 decision threshold, balanced accuracy falls to 0.585 ± 0.014 and predictions collapse toward one class. Yet the higher ROC-AUC shows that the score ordering still carries information on unseen sites.
A threshold chosen only on training sites and then transferred unchanged reaches 0.643 ± 0.034 balanced accuracy. That does not solve cross-site detection; it identifies calibration as one substantial part of the failure instead of declaring the representation empty.
04
Self-supervision did not rescue transfer
VICReg pretraining was tested through frozen probes, fine-tuning, and a label-budget sweep. Frozen cross-site probes reached 0.581 ± 0.002 AUC from OpenNeuro pretraining and 0.526 ± 0.003 from a disjoint TUH clinical corpus—below the supervised baseline.
The negative result is conditional: one architecture, bounded compute, and the tested data regimes. It says that scale and unlabeled data did not automatically remove this domain shift—not that self-supervision can never help EEG.
05
What the result permits
This is a benchmark audit, not a clinical deployment study. The evaluation covers four public datasets and only three held-out both-class sites. It does not establish a diagnostic device or performance on future hospitals.
The defensible recommendation is methodological: report a site-prior null, hold out whole sites, separate discrimination from calibration, and keep negative transfer results visible. A medical score should not become a clinical claim before its acquisition shortcuts have been tested.